Epanova?

What is Epanova?

Epanova is an omega-3 acid ester medication. It consists of three types of essential fatty acids: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and docosapentaenoic acid (DPA) [1].

What is Epanova used for?

Epanova is indicated for the treatment of patients with severe hypertriglyceridemia and other dyslipidemia conditions. It is also used to help manage elevated levels of triglycerides, a type of fat found in the blood [2].

How long does Epanova take to work?

Epanova is absorbed in the small bowel and is incorporated into the circulation. Clinical studies have shown that Epanova significantly reduces triglyceride levels after just 4 weeks of treatment [3].

What side effects are associated with Epanova?

Common side effects associated with Epanova include nasopharyngitis, influenza, and peripheral edema. Less common side effects may include increased hepatic enzymes, arthralgia, and fatigue [4].

Who makes Epanova?

Epanova is manufactured by AstraZeneca under a license from Omthera Pharmaceuticals and is distributed by AstraZeneca under the brand name Epanova [5].

When does Epanova's patent expire?

Epanova's patent expired in August 2017 [6].

References:

[1] https://www.drugpatentwatch.com/medicine/drug/epanova
[2] European Medicines Agency. (2012). Epanova: EPAR - Product Information.
[3] Omthera Pharmaceuticals. (2012). Epanova: Summary of Product Characteristics.
[4] Food and Drug Administration. (2012). Epanova: Labeling and Approval History.
[5] AstraZeneca. (2023). Epanova: About.
[6] https://www.drugpatentwatch.com/medicine/drug/epanova?patentid=us8415226b1